Searched for
PHARMEASY EXPENSES
Mother's Day Special: How AI, apps are empowering women to manage finances, improve health, build careerWomen are learning to keep pace with the ubiquitous apps and AI, shrugging off dependence on their kids for financial transactions, online ...
PharmEasy to formally discuss IPO plans with its board in second trySources told ET that online pharmacy startup PharmEasy could hit the bourses this year, two years after its previous attempt. The company w...
PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore los...
ChrysCap set to take a bite of nutraceuticals co HealthKartChrysCapital is finalizing a deal to acquire a 20% stake in HealthKart, valuing it at $450 million. Peak XV will sell their stake in the ro...
Tata 1mg’s FY24 operating revenue up 21% to Rs 1,968 croreTata 1mg’s net loss plummeted to Rs 313 crore from Rs 1,255 crore in the previous financial year. Over 80% of the company’s operating reven...
Daughter of Divi's founder shells out Rs 80 crore for two Hyderabad propertiesNilima Prasad Divi, daughter of Murali Divi, the founder of Divi's Laboratories, a prominent pharmaceutical company in India, has recently ...
Online preventive health check-ups set to grow 50% in January-March tax saving season: SimplStarting January, millions of salaried employees across India make their investment and expense declarations to save on taxes.
PharmEasy’s FY23 operating revenue up 16% to Rs 6,644 crore; net loss widens 30%PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred ...
No spending freeze at startups; Swiggy, PharmEasy FY23 report cardTop internet firms didn’t let a ‘funding winter’ dampen their urge to spend in the last fiscal, an ET analysis found. Details of this and m...
1mg pips PharmEasy in market share; what’s behind PayU’s new business forays?Tata Digital-owned 1mg has beaten rival PharmEasy to pole position in the country’s e-pharmacy market in terms of gross merchandise value. ...
Tata 1mg scale grows in FY23 but losses more than double on one-time expenseA significant chunk of the increase in Tata 1mg's loss was attributable to a Rs 668.1 crore one-time expense.
Till debt do us part: will startups go the PharmEasy way, and other top tech & startup stories this weekThis week’s ETtech newsbreak on PharmEasy going for a rights issue at a price 90% lower than its peak valuation of $5.6 billion to repay de...
In 2022, etailers trumped offline stores in smartphone shipments; PharmEasy rules out Thyrocare saleThe calendar year 2022 saw online platforms like Flipkart, Amazon overtake offline retailers in shipments of smartphones from manufacturing...
PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
NFTs power metaverse boom; PharmEasy to raise $200M before IPOThe metaverse, a term coined in science fiction in 1992, has been all over the news recently thanks to the proliferation of virtual worlds ...
Amazon, Flipkart challenge court orderFrom Amazon and Flipkart challenging HC order on CCI's antitrust probe to Twitter's standoff with govt and Satya Nadella elected as board c...
Medlife revenue up 165% to Rs 363 cr, losses surge tooIn August, Medlife appointed former Myntra CEO Ananth Narayanan as CEO and cofounder, with a mandate to head day-to-day operations, raise f...
Pharmacy aggregator Pharmeasy raises venture debt from Trifecta CapitalMore than 100 chemists are registered with Pharmeasy and have seen as much as six-fold increase in their business since they enrolled.
How to cut your medicine billsIndia is one of the largest producers of generic drugs, which account for nearly 75% of the pharmaceuticals market.